Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · DXC Technology (DXC)

DXC Technology Q2 revenue falls 4.0% to $3.03 billion; non-GAAP EPS down 20.2%

Negative Impact 3 of 5 earnings

DXC Technology reported second-quarter fiscal 2027 results for the period ended September 30, 2026, with revenue of $3.03 billion, down 4.0% year over year, and non-GAAP diluted earnings per share of $0.67, down 20.2%. GAAP diluted EPS was $0.15, compared with $0.20 a year earlier, and bookings of $2.4 billion fell 10%. The company also acknowledged ongoing discussions about a possible sale of its insurance business, while the filing gives full-year fiscal 2027 revenue guidance of $11.91 billion to $11.98 billion.

Key points

  • Q2 FY27 total revenue was $3.03 billion, down 4.0% year over year; GIS revenue fell 10.0% and CES fell 3.3%
  • Non-GAAP diluted EPS was $0.67, down 20.2%; GAAP diluted EPS was $0.15 versus $0.20 a year earlier
  • Adjusted EBIT margin was 6.2%, and free cash flow for the first half of FY27 was $405 million, compared with $337 million last year
  • DXC acknowledged ongoing discussions regarding a possible sale of its insurance business; FY27 non-GAAP diluted EPS guidance is $2.25 to $2.50

The filing

CompanyDXC Technology (DXC)
Form8-K, current report
Filed with the SECOct 29, 2026, 4:17 PM ET
Accession number0001688568-26-000089

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 7, 2026, 11:17 PM ET, from the text of the filing and its press-release exhibits only.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.